Friday, October 28, 2016

Doxazosine Sandoz




Doxazosine Sandoz may be available in the countries listed below.


Ingredient matches for Doxazosine Sandoz



Doxazosin

Doxazosin mesilate (a derivative of Doxazosin) is reported as an ingredient of Doxazosine Sandoz in the following countries:


  • Netherlands

International Drug Name Search


Soaresin




Soaresin may be available in the countries listed below.


Ingredient matches for Soaresin



Sulfasalazine

Sulfasalazine is reported as an ingredient of Soaresin in the following countries:


  • Japan

International Drug Name Search


Thursday, October 27, 2016

Onfor




Onfor may be available in the countries listed below.


Ingredient matches for Onfor



Nalbuphine

Nalbuphine hydrochloride (a derivative of Nalbuphine) is reported as an ingredient of Onfor in the following countries:


  • Argentina

International Drug Name Search


Apidra


See also: Generic Apidra Solostar


Apidra is a brand name of insulin glulisine, approved by the FDA in the following formulation(s):


APIDRA (insulin glulisine recombinant - injectable; iv (infusion)-sc)



  • Manufacturer: SANOFI AVENTIS US

    Approval date: April 16, 2004

    Strength(s): 1000 UNITS/10ML (100 UNITS/ML) [RLD]


  • Manufacturer: SANOFI AVENTIS US

    Approval date: December 20, 2005

    Strength(s): 300 UNITS/3ML (100 UNITS/ML) [RLD]

Has a generic version of Apidra been approved?


No. There is currently no therapeutically equivalent version of Apidra available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Apidra. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Insulin derivatives having a rapid onset of action
    Patent 6,221,633
    Issued: April 24, 2001
    Inventor(s): Ertl; Johann & Habermann; Paul & Geisen; Karl & Seipke; Gerhard
    Assignee(s): Aventis Pharma Deutschland GmbH
    The present invention relates to insulin derivatives which in comparison to human insulin, have an accelerated onset of action, to a process for their preparation and to their use, in particular in pharmaceutical preparations for the treatment of diabetes mellitus. In particular, the present invention relates to insulin derivatives or physiologically tolerable salts thereof in which asparagine (Asn) in position B3 of the B chain is replaced by a naturally occurring basic amino acid residue and at least one amino acid residue in the positions B27, B28 or B29 of the B chain is replaced by another naturally occurring amino acid residue, it optionally being possible for asparagine (Asn) in position 21 of the A chain to be replaced by Asp, Gly, Ser, Thr or Ala and for phenylalanine (Phe) in position B1 of the B chain and the amino acid residue in position B30 of the B chain to be absent.
    Patent expiration dates:

    • June 18, 2018
      ✓ 
      Patent use: METHOD OF TREATING A PATIENT SUFFERING FROM DIABETES MELLITUS
      ✓ 
      Drug substance
      ✓ 
      Drug product




  • Zinc-free and low-zinc insulin preparations having improved stability
    Patent 6,960,561
    Issued: November 1, 2005
    Inventor(s): Boderke; Peter
    Assignee(s): Aventis Pharma Deutschland GmbH
    The invention relates to a formulation comprising a polypeptide selected from at least one of insulin, an insulin metabolite, an insulin analog, and an insulin derivative; at least one surfactant; optionally at least one preservative; and optionally at least one of an isotonicizing agent, a buffer or an excipient, wherein the formulation is free from or low in zinc. The invention also relates to the production of such insulin preparations and their use as pharmaceutical formulations.
    Patent expiration dates:

    • January 25, 2023
      ✓ 
      Patent use: METHOD OF TREATING A PATIENT SUFFERING FROM DIABETES MELLITUS
      ✓ 
      Drug product




  • Zinc-free and low-zinc insulin preparations having improved stability
    Patent 7,452,860
    Issued: November 18, 2008
    Inventor(s): Boderke; Peter
    Assignee(s): Sanofi-Aventis Deutschland GmbH
    The invention relates to a formulation comprising a polypeptide selected from at least one of insulin, an insulin metabolite, an insulin analog, and an insulin derivative; at least one surfactant; optionally at least one preservative; and optionally at least one of an isotonicizing agent, a buffer or an excipient, wherein the formulation is free from or low in zinc. The invention also relates to the production of such insulin preparations and their use as pharmaceutical formulations.
    Patent expiration dates:

    • March 22, 2022
      ✓ 
      Drug product




  • Zinc-free and low-zinc insulin preparations having improved stability
    Patent 7,696,162
    Issued: April 13, 2010
    Inventor(s): Boderke; Peter
    Assignee(s): Sanofi-Aventis Deutschland GmbH
    The invention relates to a formulation comprising a polypeptide selected from at least one of insulin, an insulin metabolite, an insulin analog, and an insulin derivative; at least one surfactant; optionally at least one preservative; and optionally at least one of an isotonicizing agent, a buffer or an excipient, wherein the formulation is free from or low in zinc. The invention also relates to the production of such insulin preparations and their use as pharmaceutical formulations.
    Patent expiration dates:

    • March 22, 2022
      ✓ 
      Patent use: METHOD OF TREATING A PATIENT SUFFERING FROM DIABETES MELLITUS
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • October 24, 2011 - NEW PATIENT POPULATION

See also...

  • Apidra Consumer Information (Drugs.com)
  • Apidra Cartridges Consumer Information (Wolters Kluwer)
  • Apidra Vials Consumer Information (Wolters Kluwer)
  • Apidra Consumer Information (Cerner Multum)
  • Apidra OptiClik Cartridge Consumer Information (Cerner Multum)
  • Apidra Advanced Consumer Information (Micromedex)
  • Apidra AHFS DI Monographs (ASHP)
  • Insulin Glulisine Cartridges Consumer Information (Wolters Kluwer)
  • Insulin Glulisine Pens Consumer Information (Wolters Kluwer)
  • Insulin Glulisine Vials Consumer Information (Wolters Kluwer)
  • Insulin glulisine Consumer Information (Cerner Multum)
  • Insulin glulisine Subcutaneous Advanced Consumer Information (Micromedex)
  • Insulin Glulisine AHFS DI Monographs (ASHP)

Vitaminoftalmina A




Vitaminoftalmina A may be available in the countries listed below.


Ingredient matches for Vitaminoftalmina A



Retinol

Retinol is reported as an ingredient of Vitaminoftalmina A in the following countries:


  • Portugal

International Drug Name Search


Nisural




Nisural may be available in the countries listed below.


Ingredient matches for Nisural



Nimesulide

Nimesulide is reported as an ingredient of Nisural in the following countries:


  • Chile

International Drug Name Search


Stugeron-Janssen




Stugeron-Janssen may be available in the countries listed below.


Ingredient matches for Stugeron-Janssen



Cinnarizine

Cinnarizine is reported as an ingredient of Stugeron-Janssen in the following countries:


  • Vietnam

International Drug Name Search


Drovid




Drovid may be available in the countries listed below.


Ingredient matches for Drovid



Ofloxacin

Ofloxacin is reported as an ingredient of Drovid in the following countries:


  • Turkey

International Drug Name Search


Streptochinasi




Streptochinasi may be available in the countries listed below.


Ingredient matches for Streptochinasi



Streptokinase

Streptochinasi (DCIT) is known as Streptokinase in the US.

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Omeprazol Streuli




Omeprazol Streuli may be available in the countries listed below.


Ingredient matches for Omeprazol Streuli



Omeprazole

Omeprazole is reported as an ingredient of Omeprazol Streuli in the following countries:


  • Switzerland

International Drug Name Search


Doxylan




Doxylan may be available in the countries listed below.


Ingredient matches for Doxylan



Doxycycline

Doxycycline hyclate (a derivative of Doxycycline) is reported as an ingredient of Doxylan in the following countries:


  • Estonia

  • Latvia

International Drug Name Search


Dimetil




Dimetil may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Dimetil



Carvedilol

Carvedilol is reported as an ingredient of Dimetil in the following countries:


  • Germany

Sulfadimidine

Sulfadimidine sodium salt (a derivative of Sulfadimidine) is reported as an ingredient of Dimetil in the following countries:


  • Italy

International Drug Name Search


Vectical




In the US, Vectical (calcitriol topical) is a member of the drug class topical antipsoriatics and is used to treat Psoriasis.

US matches:

  • Vectical

  • Vectical Ointment

  • Vectical topical

Ingredient matches for Vectical



Calcitriol

Calcitriol is reported as an ingredient of Vectical in the following countries:


  • United States

International Drug Name Search


Herpes Simplex, Prophylaxis Medications


There are currently no drugs listed for "Herpes Simplex, Prophylaxis". See Herpes Simplex.





Drug List:


Conjunctivitis, Bacterial Medications


Definition of Conjunctivitis, Bacterial:

A bacterial infection of a portion of the eye known as the conjunctiva.


Common symptoms include redness of the eyes with a thick, often coloured purulent discharge.

More...

Drugs associated with Conjunctivitis, Bacterial

The following drugs and medications are in some way related to, or used in the treatment of Conjunctivitis, Bacterial. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Conjunctivitis, Bacterial





Drug List:


Sucrahasan




Sucrahasan may be available in the countries listed below.


Ingredient matches for Sucrahasan



Sucralfate

Sucralfate is reported as an ingredient of Sucrahasan in the following countries:


  • Vietnam

International Drug Name Search


Nicozone




Nicozone may be available in the countries listed below.


Ingredient matches for Nicozone



Ketoconazole

Ketoconazole is reported as an ingredient of Nicozone in the following countries:


  • Singapore

International Drug Name Search


Wednesday, October 26, 2016

Sodio Edetato




Sodio Edetato may be available in the countries listed below.


Ingredient matches for Sodio Edetato



Edetic Acid

Edetic Acid disodium salt (a derivative of Edetic Acid) is reported as an ingredient of Sodio Edetato in the following countries:


  • Italy

International Drug Name Search


Naftidrofuryl




UK matches:

  • Naftidrofuryl Capsules 100mg (Actavis UK Ltd)
  • Naftidrofuryl Capsules 100mg (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C04AX21

CAS registry number (Chemical Abstracts Service)

0031329-57-4

Chemical Formula

C24-H33-N-O3

Molecular Weight

383

Therapeutic Category

Vasodilator, peripheric

Chemical Name

2-Furanpropanoic acid, tetrahydro-α-(1-naphthalenylmethyl)-, 2-(diethylamino)ethyl ester

Foreign Names

  • Naftidrofurylum (Latin)
  • Naftidrofuryl (German)
  • Naftidrofuryl (French)
  • Naftidrofurilo (Spanish)

Generic Names

  • Naftidrofurile (OS: DCIT)
  • Naftidrofuryl (OS: BAN, DCF)
  • EU-1806 (IS)
  • LS 121 (IS)
  • Nafronyl (IS)
  • Nafronyl Oxalate (OS: USAN)
  • Naftidrofuryl Oxalate (OS: BANM)
  • Naftidrofuryl (oxalate acide de) (PH: Ph. Eur. 6)
  • Naftidrofuryl Hydrogen Oxalate (PH: Ph. Eur. 6)
  • Naftidrofuryl hydrogenoxalat (PH: Ph. Eur. 6)
  • Naftidrofuryl Oxalate (PH: BP 2010)
  • Naftidrofuryli hydrogenooxalas (PH: Ph. Eur. 6)

Brand Names

  • Drosunal
    Actavis, Georgia; Balkanpharma, Bulgaria


  • Iridux
    Sanofi-Aventis, Brazil


  • Praxilene
    Merck Génériques, Tunisia


  • Diactane
    Menarini, France


  • Dusodril retard
    Merck, Austria


  • Dusodril
    Famar, Bulgaria; Merck, Germany; Merck KGaA, Romania


  • Dusopharm
    Unipharm, Bulgaria


  • Enelbin
    Stada, Slovakia; Zentiva, Czech Republic; Zentiva, Estonia; Zentiva, Latvia


  • Frilix
    Pharos, Indonesia


  • Gévatran
    Merck Serono, France


  • Iridus
    Sanofi-Aventis, Mexico; Sanofi-Aventis, Venezuela


  • Nafoxal
    Sandoz, Indonesia


  • Nafrolen
    Remedica, Cyprus


  • Nafti-CT
    CT Arzneimittel, Germany


  • Naftidrofuryl Alter
    Alter, France


  • Naftidrofuryl EG
    EG Labo, France


  • Naftidrofuryl Mylan
    Mylan, France


  • Naftidrofuryl Nor
    Biogaran, France


  • Naftidrofuryl Qualimed
    Qualimed, France


  • Naftidrofuryl Ranbaxy
    Ranbaxy, France


  • Naftidrofuryl Ratiopharm
    Ratiopharm, France


  • Naftidrofuryl Teva
    Teva Santé, France


  • Naftidrofuryl Winthrop
    Sanofi-Aventis, France


  • Naftidrofuryl
    Actavis, United Kingdom


  • Naftilong
    Hexal, Germany; Hexal, Hungary; Hexal, Luxembourg


  • Naftilux
    Therabel, France


  • Nafti-Puren
    Actavis, Germany


  • Nafti-ratiopharm
    Ratiopharm, Germany


  • Nafti-Sandoz
    Sandoz, Germany


  • Praxilene
    Aktuapharma, Belgium; Faes, Spain; Famar Lyon, Vietnam; Formenti, Italy; Merck, Belgium; Merck, Switzerland; Merck, Hong Kong; Merck, Indonesia; Merck, Ireland; Merck, Luxembourg; Merck, Peru; Merck, Philippines; Merck, Portugal; Merck, Singapore; Merck, Thailand; Merck Serono, United Kingdom; MSD, Georgia; Remek, Greece


  • Praxilène
    Merck Lipha Santé, France


  • Sodipryl
    Sanofi, Switzerland


  • Vascuprax
    Ikapharmindo, Indonesia; Lipha, Indonesia

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
SPC Summary of Product Characteristics (UK)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Starxon




Starxon may be available in the countries listed below.


Ingredient matches for Starxon



Ceftriaxone

Ceftriaxone is reported as an ingredient of Starxon in the following countries:


  • Indonesia

International Drug Name Search


Antihistamines


A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

Antihistamines are drugs that inhibit the action of histamine in the body by blocking the receptors of histamine. There are two types of histamine receptors H1 and H2. When H1 receptors are stimulated by histamine it may produce allergic reactions such as itching, hay fever and rash or hives.


Antihistamines treat the symptoms of allergic reactions. Some antihistamines are sedating and although some are classed as non-sedating antihistamines, they may still cause drowsiness in some people.

See also

Medical conditions associated with antihistamines:

  • Allergic Reactions
  • Allergic Urticaria
  • Allergies
  • Anaphylaxis
  • Anorexia
  • Anorexia Nervosa
  • Anxiety
  • Cluster Headaches
  • Cold Symptoms
  • Conjunctivitis, Allergic
  • Cough
  • Cushing's Syndrome
  • Dermatographism
  • Extrapyramidal Reaction
  • Eye Dryness/Redness
  • Eye Redness/Itching
  • Failure to Thrive
  • Hay Fever
  • Insomnia
  • Interstitial Cystitis
  • Light Sedation
  • Migraine
  • Motion Sickness
  • Nasal Congestion
  • Nausea/Vomiting
  • Opiate Adjunct
  • Pain
  • Pruritus
  • Rhinorrhea
  • Sedation
  • Sexual Dysfunction, SSRI Induced
  • Upper Respiratory Tract Infection
  • Urticaria
  • Vasomotor Rhinitis
  • Vertigo

Drug List:


Ovral




In the US, Ovral is a member of the drug class contraceptives and is used to treat Abnormal Uterine Bleeding, Birth Control, Emergency Contraception, Endometriosis and Gonadotropin Inhibition.

Ingredient matches for Ovral



Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Ovral in the following countries:


  • Ethiopia

  • South Africa

  • United States

Norgestrel

Norgestrel is reported as an ingredient of Ovral in the following countries:


  • Canada

  • Ethiopia

  • South Africa

  • United States

International Drug Name Search


Vertizine




Vertizine may be available in the countries listed below.


Ingredient matches for Vertizine



Cinnarizine

Cinnarizine is reported as an ingredient of Vertizine in the following countries:


  • Indonesia

International Drug Name Search


Virbamec LV Pour-On




Virbamec LV Pour-On may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Virbamec LV Pour-On



Ivermectin

Ivermectin is reported as an ingredient of Virbamec LV Pour-On in the following countries:


  • Australia

International Drug Name Search


Tuesday, October 25, 2016

Superan




Superan may be available in the countries listed below.


Ingredient matches for Superan



Alizapride

Alizapride hydrochloride (a derivative of Alizapride) is reported as an ingredient of Superan in the following countries:


  • Brazil

International Drug Name Search


Dothiepin Hydrochloride




Dothiepin Hydrochloride may be available in the countries listed below.


Ingredient matches for Dothiepin Hydrochloride



Dosulepin

Dothiepin Hydrochloride (USAN) is also known as Dosulepin (Rec.INN)

International Drug Name Search

Glossary

Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

DoxaLEK




DoxaLEK may be available in the countries listed below.


Ingredient matches for DoxaLEK



Doxazosin

Doxazosin is reported as an ingredient of DoxaLEK in the following countries:


  • Poland

International Drug Name Search


Unipride




Unipride may be available in the countries listed below.


Ingredient matches for Unipride



Cisapride

Cisapride monohydrate (a derivative of Cisapride) is reported as an ingredient of Unipride in the following countries:


  • India

International Drug Name Search


Hantina




Hantina may be available in the countries listed below.


Ingredient matches for Hantina



Nitrofural

Nitrofural is reported as an ingredient of Hantina in the following countries:


  • Brazil

International Drug Name Search


Navigator




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Navigator



Nitazoxanide

Nitazoxanide is reported as an ingredient of Navigator in the following countries:


  • United States

International Drug Name Search


Valproate de sodium Arrow




Valproate de sodium Arrow may be available in the countries listed below.


Ingredient matches for Valproate de sodium Arrow



Valproic Acid

Valproic Acid sodium (a derivative of Valproic Acid) is reported as an ingredient of Valproate de sodium Arrow in the following countries:


  • France

International Drug Name Search


Vibranord




Vibranord may be available in the countries listed below.


Ingredient matches for Vibranord



Doxycycline

Doxycycline hyclate (a derivative of Doxycycline) is reported as an ingredient of Vibranord in the following countries:


  • Sweden

International Drug Name Search


Sopitam




Sopitam may be available in the countries listed below.


Ingredient matches for Sopitam



Timepidium Bromide

Timepidium Bromide is reported as an ingredient of Sopitam in the following countries:


  • Japan

International Drug Name Search


Monday, October 24, 2016

Hydroxyzine




In some countries, this medicine may only be approved for veterinary use.


In the US, Hydroxyzine (hydroxyzine systemic) is a member of the following drug classes: antihistamines, miscellaneous anxiolytics, sedatives and hypnotics and is used to treat Allergic Urticaria, Anxiety, Nausea/Vomiting, Pain, Pruritus and Sedation.

US matches:

  • Hydroxyzine

  • Hydroxyzine Capsules

  • Hydroxyzine Suspension

  • Hydroxyzine Syrup

  • Hydroxyzine Hydrochloride

  • Hydroxyzine Pamoate

  • Hydroxyzine Oral Solution

  • Hydroxyzine Tablets

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N05BB01

CAS registry number (Chemical Abstracts Service)

0000068-88-2

Chemical Formula

C21-H27-Cl-N2-O2

Molecular Weight

374

Therapeutic Category

Anxiolytic agent

Chemical Name

Ethanol, 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-

Foreign Names

  • Hydroxyzinum (Latin)
  • Hydroxyzin (German)
  • Hydroxyzine (French)
  • Hidroxizina (Spanish)

Generic Names

  • Hydroxyzine (OS: DCF, BAN)
  • Idroxizina (OS: DCIT)
  • UCB 4492 (IS: UCB)
  • Hydroxyzine Pamoate (OS: JAN)
  • Hydroxyzine Pamoate (PH: USP 32, JP XIV)
  • Hydroxyzine Hydrochloride (OS: BANM)
  • Hydroxyzine dihydrochloride (IS)
  • Hydroxyzindihydrochlorid (PH: Ph. Eur. 6)
  • Hydroxyzine (chlorhydrate d') (PH: Ph. Eur. 6)
  • Hydroxyzine Hydrochloride (PH: BP 2010, Ph. Eur. 6, USP 32, JP XIV)
  • Hydroxyzini hydrochloridum (PH: Ph. Eur. 6)

Brand Names

  • Apo-Hydroxyzine
    Apotex, Vietnam


  • Atarax
    IBN, Tunisia; UCB, Bulgaria; UCB, Tunisia


  • Dormirex
    Lafrancol, Guatemala


  • Hidroxicina Genfar
    Genfar, Colombia; Genfar, Ecuador


  • Hydroxyzine HCL
    Mutual, United States


  • Hytis
    General Pharma, Bangladesh


  • Qualidrozine
    Quality, Hong Kong


  • Atarax-P
    Pfizer, Japan


  • Hatanazin
    Nisshin Seiyaku - Yamagata, Japan


  • Hyderax
    HLB, Argentina


  • Hydroxyzine Pamoate
    Sandoz, United States; Teva USA, United States; Watson, United States


  • Vistaril
    Pfizer, Taiwan; Pfizer, United States


  • AH 3
    UCB, Germany


  • Anx
    Econo Med, United States


  • Apo-Hydroxyzine
    Apotex, Canada; Apotex, Hong Kong; Apotex, Singapore


  • Atarax
    ACI, Bangladesh; Alfa, Peru; Alliance, United Arab Emirates; Alliance, Egypt; Alliance, United Kingdom; Alliance, Iraq; Alliance, Iran; Alliance, Jordan; Alliance, Kuwait; Alliance, Lebanon; Alliance, Qatar; Alliance, Saudi Arabia; Alliance, Syria; Alliance, Yemen; Pfizer, Guyana; Pfizer, Japan; Pfizer, United States; Solvay, Russian Federation; UCB, Austria; UCB, Belgium; UCB, Burkina Faso; UCB, Bahrain; UCB, Burundi; UCB, Benin; UCB, Central African Republic; UCB, Congo; UCB, Cote D'ivoire; UCB, Cameroon; UCB, Czech Republic; UCB, Germany; UCB, Denmark; UCB, Algeria; UCB, Spain; UCB, Finland; UCB, France; UCB, Gabon; UCB, Georgia; UCB, Guinea; UCB, Greece; UCB, Hong Kong; UCB, Hungary; UCB, India; UCB, Iceland; UCB, Italy; UCB, Luxembourg; UCB, Madagascar; UCB, Mali; UCB, Mauritania; UCB, Mauritius; UCB, Mexico; UCB, Malaysia; UCB, Niger; UCB, Netherlands; UCB, Norway; UCB, Oman; UCB, Poland; UCB, Portugal; UCB, Sweden; UCB, Singapore; UCB, Senegal; UCB, Chad; UCB, Togo; UCB, Thailand; UCB, Turkey; UCB, Taiwan; UCB, Taiwan; UCB, Zaire; UCB Pharma, Malta; UCB-Pharma, Switzerland


  • Atarax (veterinary use)
    Pfizer Animal Health, United Kingdom


  • Ataraxone
    Lazar, Argentina


  • Atarax-P
    Pfizer, Japan


  • Aterax
    UCB, South Africa


  • Bestalin
    Lapi Laboratories, Indonesia


  • Cedar
    Psipharma, Colombia


  • Dalun
    Medipharm, Chile


  • Disron
    Nagase Iyakuhin, Japan


  • Fasarax
    Prater, Chile


  • Fedox
    Mediderm, Chile


  • Hiderax
    Lafrancol, Colombia


  • Hidroxicina La Santé
    La Santé, Colombia


  • Hidroxizin
    Sicomed, Romania


  • Histacalmine (Hydroxyzine and Chlorphenamine (veterinary use))
    Virbac, France


  • Histaderm (Hydroxyzine and Chlorphenamine (veterinary use))
    Sogeval, France


  • Hydroxyzine Europharm
    Europharm, Hong Kong


  • Hydroxyzine HCL
    Actavis, United States; Amneal, United States; Andapharm, United States; Hetero, United States; Hi-Tech, United States; InvaGen, United States; KVK Tech, United States; Luitpold, United States; Morton Grove, United States; Northstar, United States; Pliva, United States; Sandoz, United States; Sun, United States; Teva USA, United States; UCB, Netherlands; Vintage, United States; Watson, United States


  • Hydroxyzine Renaudin
    Renaudin, France


  • Hydroxyzinum
    ICN, Lithuania; ICN, Poland; Pliva, Poland; Polon, Poland


  • Iremofar
    Uni-Pharma, Greece


  • Iterax
    UCB, Indonesia; UCB, Philippines


  • Neucalm
    Legere, United States


  • Neurax
    Merck Generics, South Africa


  • Neurolax
    Actavis, Georgia


  • Otarex
    Teva, Israel


  • Ucerax
    UCB, United Arab Emirates; UCB, Bahrain; UCB, Egypt; UCB, Ireland; UCB, Iraq; UCB, Iran; UCB, Jordan; UCB, Kuwait; UCB, Lebanon; UCB, Oman; UCB, Qatar; UCB, Saudi Arabia; UCB, Syria; UCB, Yemen; UCB Pharma, United Kingdom


  • Ucerax (veterinary use)
    UCB, United Kingdom


  • Vetaraxoid (Hydroxyzine and Prednisolone (veterinary use))
    Pfizer, Austria; Pfizer Animal Health, Finland


  • Vistaril
    Pfizer, United States

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Dopaston




Dopaston may be available in the countries listed below.


Ingredient matches for Dopaston



Levodopa

Levodopa is reported as an ingredient of Dopaston in the following countries:


  • Japan

International Drug Name Search


Sapbufen




Sapbufen may be available in the countries listed below.


Ingredient matches for Sapbufen



Ibuprofen

Ibuprofen is reported as an ingredient of Sapbufen in the following countries:


  • Algeria

International Drug Name Search


Neomicina Salvat




Neomicina Salvat may be available in the countries listed below.


Ingredient matches for Neomicina Salvat



Neomycin

Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Neomicina Salvat in the following countries:


  • Spain

International Drug Name Search


Nizadin




Nizadin may be available in the countries listed below.


Ingredient matches for Nizadin



Nizatidine

Nizatidine is reported as an ingredient of Nizadin in the following countries:


  • Taiwan

International Drug Name Search


Niterat




Niterat may be available in the countries listed below.


Ingredient matches for Niterat



Norfloxacin

Norfloxacin is reported as an ingredient of Niterat in the following countries:


  • Colombia

International Drug Name Search


Pathological Hypersecretory Conditions Medications


Drugs associated with Pathological Hypersecretory Conditions

The following drugs and medications are in some way related to, or used in the treatment of Pathological Hypersecretory Conditions. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.





Drug List:


Scanaflam




Scanaflam may be available in the countries listed below.


Ingredient matches for Scanaflam



Diclofenac

Diclofenac potassium salt (a derivative of Diclofenac) is reported as an ingredient of Scanaflam in the following countries:


  • Indonesia

International Drug Name Search


Sunday, October 23, 2016

Burkitt Lymphoma Medications


There are currently no drugs listed for "Burkitt Lymphoma".

Learn more about Burkitt Lymphoma





Drug List:


Oforta


Oforta is a brand name of fludarabine, approved by the FDA in the following formulation(s):


OFORTA (fludarabine phosphate - tablet; oral)



  • Manufacturer: SANOFI AVENTIS US

    Approval date: December 18, 2008

    Strength(s): 10MG [RLD]

Has a generic version of Oforta been approved?


No. There is currently no therapeutically equivalent version of Oforta available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Oforta. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Oral fludara of high-purity formulation with quick release of active ingredient
    Patent 7,148,207
    Issued: December 12, 2006
    Inventor(s): Heil; Wolfgang & Tistam; Ulf & Lipp; Ralph & Tack; Johannes-Wilhelm
    Assignee(s): Schering Aktiengesellschaft
    This invention relates to a quick-release tablet formulation with >99.19% pure fludara (high-purity fludara) as an active ingredient in a defined composition of residual contaminants.
    Patent expiration dates:

    • December 20, 2022
      ✓ 
      Patent use: TREATMENT OF PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
      ✓ 
      Drug product




  • Process for the production of fludarabine-phosphate lithium, sodium, potassium, calcium and magnesium salts and purification process for the production of fludarabine-phosphate and fludarabine-phosphate with a purity of at least 99.5%
    Patent 7,547,776
    Issued: June 16, 2009
    Inventor(s): Tilstam; Ulf & Schmitz; Thomas & Nickisch; Klaus
    Assignee(s): Bayer Schering Pharma Aktiengesellschaft
    The present invention generally relates to a fludarabine-phosphate with a purity of at least 99.5%.
    Patent expiration dates:

    • December 10, 2018
      ✓ 
      Drug substance



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • December 18, 2011 - NEW DOSAGE FORM

    • December 18, 2015 - ORPHAN DRUG EXCLUSIVITY

See also...

  • Oforta Consumer Information (Drugs.com)
  • Oforta Consumer Information (Wolters Kluwer)
  • Oforta Consumer Information (Cerner Multum)
  • Oforta Advanced Consumer Information (Micromedex)
  • Fludarabine Consumer Information (Wolters Kluwer)
  • Fludarabine Tablets Consumer Information (Wolters Kluwer)
  • Fludarabine Consumer Information (Cerner Multum)
  • Fludarabine injection Consumer Information (Cerner Multum)
  • Fludarabine Advanced Consumer Information (Micromedex)
  • Fludarabine Intravenous Advanced Consumer Information (Micromedex)
  • Fludarabine Phosphate AHFS DI Monographs (ASHP)

Dihydroergocristine




Scheme

BAN

ATC (Anatomical Therapeutic Chemical Classification)

C04AE04

CAS registry number (Chemical Abstracts Service)

0017479-19-5

Chemical Formula

C35-H41-N5-O5

Molecular Weight

611

Therapeutic Category

Vasodilator, peripheric

Chemical Name

Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-(1-methylethyl)-5'-(phenylmethyl)-, (5'α,10α)-

Foreign Names

  • Dihydroergocristin (German)
  • Dihydroergocristine (French)

Generic Names

  • Dihydroergocristine (OS: DCF, BAN)
  • DF 69 (IS)
  • Dihydroergocristine Mesilate (OS: BAN)
  • Dihydroergocristine methanesulfonate (IS)
  • Dihydroergocristine (mésilate de) (PH: Ph. Eur. 6)
  • Dihydroergocristine Mesilate (PH: BP 2010, Ph. Eur. 6)
  • Dihydroergocristini mesilas (PH: Ph. Eur. 6)
  • Dihydroergocristinmesilat (PH: Ph. Eur. 6)

Brand Names

  • Brinerdin (Dihydroergocristine and Clopamide, + Reserpine)
    Krka, Slovenia; Novartis, South Africa


  • Agiobita
    S.J.A., Greece


  • Almirid
    Polichem, Czech Republic


  • Anavenol
    Zentiva, Georgia


  • Beytina
    Leovan, Greece


  • Brinerdin (Dihydroergocristine and Clopamide, + Reserpine)
    Novartis, Bahrain; Novartis, Switzerland; Novartis, Oman


  • Clinadil (Dihydroergocristine and Cinnarizine)
    Stada, Spain


  • Crystepin
    Zentiva, Georgia


  • Diemil (Dihydroergocristine and Piracetam)
    Almirall, Spain


  • Diertina
    Pharmanel, Greece; Sankyo, Portugal


  • Diertine
    Astellas, Spain


  • Ergodavur
    Davur, Spain


  • Ergofil
    Vocate, Greece


  • Ersilan (Dihydroergocristine and Etofylline)
    Ivax, Slovakia


  • Fenitina
    Leovan, Greece


  • Hydergine
    Novartis, Hong Kong


  • Iskédyl (Dihydroergocristine and Raubasine)
    Pierre Fabre Médicament, France


  • Iskemil
    Aché, Brazil


  • Memotil
    Genepharm, Greece


  • Nehydrin
    Sanochemia, Austria


  • Vasobral
    CNW, Hong Kong

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Hibadren




Hibadren may be available in the countries listed below.


Ingredient matches for Hibadren



Doxazosin

Doxazosin mesilate (a derivative of Doxazosin) is reported as an ingredient of Hibadren in the following countries:


  • Austria

International Drug Name Search


Diclofenaco Gel




Diclofenaco Gel may be available in the countries listed below.


Ingredient matches for Diclofenaco Gel



Diclofenac

Diclofenac diethylamine (a derivative of Diclofenac) is reported as an ingredient of Diclofenaco Gel in the following countries:


  • Chile

International Drug Name Search


Solpenox




Solpenox may be available in the countries listed below.


Ingredient matches for Solpenox



Amoxicillin

Amoxicillin is reported as an ingredient of Solpenox in the following countries:


  • Indonesia

International Drug Name Search


Simirex




Simirex may be available in the countries listed below.


Ingredient matches for Simirex



Simvastatin

Simvastatin is reported as an ingredient of Simirex in the following countries:


  • Czech Republic

International Drug Name Search


Sopyrat




Sopyrat may be available in the countries listed below.


Ingredient matches for Sopyrat



Disopyramide

Disopyramide is reported as an ingredient of Sopyrat in the following countries:


  • Japan

International Drug Name Search


Doc Furose




Doc Furose may be available in the countries listed below.


Ingredient matches for Doc Furose



Furosemide

Furosemide is reported as an ingredient of Doc Furose in the following countries:


  • Luxembourg

International Drug Name Search


Verapamil 1A Farma




Verapamil 1A Farma may be available in the countries listed below.


Ingredient matches for Verapamil 1A Farma



Verapamil

Verapamil hydrochloride (a derivative of Verapamil) is reported as an ingredient of Verapamil 1A Farma in the following countries:


  • Denmark

International Drug Name Search


Helozym




Helozym may be available in the countries listed below.


Ingredient matches for Helozym



Clarithromycin

Clarithromycin is reported as an ingredient of Helozym in the following countries:


  • Costa Rica

International Drug Name Search


Saturday, October 22, 2016

Vivelle


See also: Generic Vivelle-Dot


Vivelle is a brand name of estradiol, approved by the FDA in the following formulation(s):


VIVELLE (estradiol - film, extended release; transdermal)



  • Manufacturer: NOVARTIS

    Approval date: October 28, 1994

    Strength(s): 0.05MG/24HR [AB1], 0.1MG/24HR [AB1]

Has a generic version of Vivelle been approved?


No. There is currently no therapeutically equivalent version of Vivelle available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Vivelle. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Vivelle.

See also...

  • Vivelle Patch Consumer Information (Wolters Kluwer)
  • Vivelle Consumer Information (Cerner Multum)
  • Estradiol Consumer Information (Drugs.com)
  • Estradiol Consumer Information (Wolters Kluwer)
  • Estradiol Acetate Consumer Information (Wolters Kluwer)
  • Estradiol Cypionate Consumer Information (Wolters Kluwer)
  • Estradiol Gel Consumer Information (Wolters Kluwer)
  • Estradiol Gel Packets Consumer Information (Wolters Kluwer)
  • Estradiol Patch Consumer Information (Wolters Kluwer)
  • Estradiol Ring Consumer Information (Wolters Kluwer)
  • Estradiol Spray Consumer Information (Wolters Kluwer)
  • Estradiol Valerate Consumer Information (Wolters Kluwer)
  • Estradiol Weekly Patch Consumer Information (Wolters Kluwer)
  • Estring Ring Consumer Information (Wolters Kluwer)
  • Estradiol injection Consumer Information (Cerner Multum)
  • Estradiol oral Consumer Information (Cerner Multum)
  • Estradiol topical for use on skin Consumer Information (Cerner Multum)
  • Estradiol transdermal Consumer Information (Cerner Multum)
  • Estradiol vaginal Consumer Information (Cerner Multum)
  • Estradiol AHFS DI Monographs (ASHP)

Simicon




Simicon may be available in the countries listed below.


Ingredient matches for Simicon



Simeticone

Simeticone is reported as an ingredient of Simicon in the following countries:


  • Bangladesh

International Drug Name Search


Sodipryl




Sodipryl may be available in the countries listed below.


Ingredient matches for Sodipryl



Naftidrofuryl

Naftidrofuryl oxalate (a derivative of Naftidrofuryl) is reported as an ingredient of Sodipryl in the following countries:


  • Switzerland

International Drug Name Search


Sodio ascorbato




Sodio ascorbato may be available in the countries listed below.


Ingredient matches for Sodio ascorbato



Ascorbic Acid

Sodio ascorbato (DCIT) is known as Ascorbic Acid in the US.

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Nafti-ratiopharm




Nafti-ratiopharm may be available in the countries listed below.


Ingredient matches for Nafti-ratiopharm



Naftidrofuryl

Naftidrofuryl oxalate (a derivative of Naftidrofuryl) is reported as an ingredient of Nafti-ratiopharm in the following countries:


  • Germany

International Drug Name Search


Ossicalf




Ossicalf may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Ossicalf



Oxytetracycline

Oxytetracycline is reported as an ingredient of Ossicalf in the following countries:


  • Italy

International Drug Name Search


Wellbutrin


See also: Generic Wellbutrin SR, Generic Wellbutrin XL


Wellbutrin is a brand name of bupropion, approved by the FDA in the following formulation(s):


WELLBUTRIN (bupropion hydrochloride - tablet; oral)



  • Manufacturer: GLAXOSMITHKLINE

    Approval date: December 30, 1985

    Strength(s): 100MG [RLD][AB], 75MG [AB]

Has a generic version of Wellbutrin been approved?


Yes. The following products are equivalent to Wellbutrin:


bupropion hydrochloride tablet; oral



  • Manufacturer: APOTEX INC

    Approval date: January 17, 2006

    Strength(s): 100MG [AB], 75MG [AB]


  • Manufacturer: MYLAN

    Approval date: April 17, 2000

    Strength(s): 100MG [AB], 75MG [AB]


  • Manufacturer: SANDOZ

    Approval date: February 7, 2000

    Strength(s): 100MG [AB], 75MG [AB]


  • Manufacturer: TEVA

    Approval date: November 29, 1999

    Strength(s): 100MG [AB], 75MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Wellbutrin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Wellbutrin.

See also...

  • Wellbutrin Consumer Information (Drugs.com)
  • Wellbutrin Consumer Information (Wolters Kluwer)
  • Wellbutrin Consumer Information (Cerner Multum)
  • Wellbutrin Advanced Consumer Information (Micromedex)
  • Bupropion Consumer Information (Drugs.com)
  • Bupropion Consumer Information (Wolters Kluwer)
  • Bupropion Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Bupropion Hydrobromide Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Bupropion Sustained-Release Tablets Consumer Information (Wolters Kluwer)
  • Bupropion Consumer Information (Cerner Multum)
  • Bupropion Advanced Consumer Information (Micromedex)
  • Bupropion Hydrochloride AHFS DI Monographs (ASHP)

Securgin




Securgin may be available in the countries listed below.


Ingredient matches for Securgin



Desogestrel

Desogestrel is reported as an ingredient of Securgin in the following countries:


  • Italy

Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Securgin in the following countries:


  • Italy

International Drug Name Search


Sebercim




Sebercim may be available in the countries listed below.


Ingredient matches for Sebercim



Norfloxacin

Norfloxacin is reported as an ingredient of Sebercim in the following countries:


  • Italy

International Drug Name Search


Friday, October 21, 2016

Oxytel




Oxytel may be available in the countries listed below.


Ingredient matches for Oxytel



Tenoxicam

Tenoxicam is reported as an ingredient of Oxytel in the following countries:


  • Greece

International Drug Name Search


Urinary Tract Tumors Medications


Drugs associated with Urinary Tract Tumors

The following drugs and medications are in some way related to, or used in the treatment of Urinary Tract Tumors. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Urinary Tract Tumors





Drug List:


Velaral




Velaral may be available in the countries listed below.


Ingredient matches for Velaral



Loperamide

Loperamide hydrochloride (a derivative of Loperamide) is reported as an ingredient of Velaral in the following countries:


  • Ecuador

International Drug Name Search


Diltiazem Genfar




Diltiazem Genfar may be available in the countries listed below.


Ingredient matches for Diltiazem Genfar



Diltiazem

Diltiazem is reported as an ingredient of Diltiazem Genfar in the following countries:


  • Colombia

  • Ecuador

  • Peru

International Drug Name Search


Naloxone Hydrochloride and Pentazocaine




Ingredient matches for Naloxone Hydrochloride and Pentazocaine



Naloxone

Naloxone hydrochloride (a derivative of Naloxone) is reported as an ingredient of Naloxone Hydrochloride and Pentazocaine in the following countries:


  • United States

Pentazocine

Pentazocine hydrochloride (a derivative of Pentazocine) is reported as an ingredient of Naloxone Hydrochloride and Pentazocaine in the following countries:


  • United States

International Drug Name Search


Flexeril


Flexeril is a brand name of cyclobenzaprine, approved by the FDA in the following formulation(s):


FLEXERIL (cyclobenzaprine hydrochloride - tablet; oral)



  • Manufacturer: JANSSEN R AND D

    Approved Prior to Jan 1, 1982

    Strength(s): 10MG [RLD][AB], 5MG [AB]

Has a generic version of Flexeril been approved?


Yes. The following products are equivalent to Flexeril:


cyclobenzaprine hydrochloride tablet; oral



  • Manufacturer: AUROBINDO PHARMA

    Approval date: September 26, 2008

    Strength(s): 10MG [AB], 5MG [AB]


  • Manufacturer: INVAGEN PHARMS

    Approval date: July 23, 2010

    Strength(s): 10MG [AB], 5MG [AB]


  • Manufacturer: JUBILANT CADISTA

    Approval date: April 19, 2006

    Strength(s): 10MG [AB], 5MG [AB]


  • Manufacturer: KVK TECH

    Approval date: February 28, 2011

    Strength(s): 10MG [AB], 5MG [AB]


  • Manufacturer: MUTUAL PHARM

    Approval date: May 23, 1995

    Strength(s): 10MG [AB]


  • Manufacturer: MUTUAL PHARM

    Approval date: April 6, 2006

    Strength(s): 5MG [AB]


  • Manufacturer: MYLAN

    Approval date: May 30, 1991

    Strength(s): 10MG [AB]


  • Manufacturer: MYLAN

    Approval date: February 3, 2006

    Strength(s): 5MG [AB]


  • Manufacturer: ORIT LABS LLC

    Approval date: April 18, 2008

    Strength(s): 10MG [AB]


  • Manufacturer: PLIVA

    Approval date: September 29, 1995

    Strength(s): 10MG [AB]


  • Manufacturer: PROSAM LABS

    Approval date: October 4, 2005

    Strength(s): 10MG [AB]


  • Manufacturer: PROSAM LABS

    Approval date: February 3, 2006

    Strength(s): 5MG [AB]


  • Manufacturer: RANBAXY

    Approval date: May 12, 2008

    Strength(s): 10MG [AB], 5MG [AB]


  • Manufacturer: SANDOZ

    Approval date: November 19, 1991

    Strength(s): 10MG [AB]


  • Manufacturer: SANDOZ

    Approval date: February 3, 2006

    Strength(s): 5MG [AB]


  • Manufacturer: VINTAGE PHARMS

    Approval date: February 28, 2007

    Strength(s): 10MG [AB], 5MG [AB]


  • Manufacturer: WATSON LABS

    Approval date: May 3, 1989

    Strength(s): 10MG [AB]


  • Manufacturer: WATSON LABS

    Approval date: February 3, 2006

    Strength(s): 5MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Flexeril. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Flexeril.

See also...

  • Flexeril Consumer Information (Drugs.com)
  • Flexeril Consumer Information (Wolters Kluwer)
  • Flexeril Consumer Information (Cerner Multum)
  • Flexeril Advanced Consumer Information (Micromedex)
  • Flexeril AHFS DI Monographs (ASHP)
  • Cyclobenzaprine Consumer Information (Drugs.com)
  • Cyclobenzaprine Consumer Information (Wolters Kluwer)
  • Cyclobenzaprine Extended-Release Capsules Consumer Information (Wolters Kluwer)
  • Cyclobenzaprine Consumer Information (Cerner Multum)
  • FusePaq Tabradol Advanced Consumer Information (Micromedex)
  • Cyclobenzaprine Advanced Consumer Information (Micromedex)
  • Cyclobenzaprine AHFS DI Monographs (ASHP)